Melanocortin signaling in the CNS directly regulates circulating cholesterol

Nature Neuroscience

Volumn 13, Issue 7, 2010, Pages 877-882

  Perez Tilve, Diego ^a   Hofmann, Susanna M ^a   Basford, Joshua ^a   Nogueiras, Ruben ^a   Pfluger, Paul T ^a   Patterson, James T ^b   Grant, Erin ^a   Wilson Perez, Hilary E ^a   Granholm, Norman A ^a   Arnold, Myrtha ^c   Trevaskis, James L ^d,f   Butler, Andrew A ^d,g   Davidson, William S ^a   Woods, Stephen C ^a   Benoit, Stephen C ^a   Sleeman, Mark W ^e   Dimarchi, Richard D ^b   Hui, David Y ^a   Tschöp, Matthias H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c ETH ZURICH   (Switzerland)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e REGENERON PHARMACEUTICALS INC   (United States)

^f AMYLIN PHARMACEUTICALS INC   (United States)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GHRELIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MELANOCORTIN; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CAPILLARY FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET; FOOD INTAKE; HYPERPHAGIA; LIPOPROTEIN METABOLISM; LIVER METABOLISM; METABOLIC DISORDER; MOUSE; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD36; BODY WEIGHT; CHOLESTEROL, HDL; EATING; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HYPOTHALAMUS; LIVER; MELANOCORTINS; MICE; MICE, KNOCKOUT; NEUROSECRETORY SYSTEMS; RATS; RATS, WISTAR; RECEPTORS, MELANOCORTIN; SCAVENGER RECEPTORS, CLASS B;

EID: 77954107681     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2569     Document Type: Article

References (42)

1. Grundy, S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J. Clin. Endocrinol. Metab. 92, 399-404 (2007).
2. Cummings, D.E. Ghrelin and the short-and long-term regulation of appetite and body weight. Physiol. Behav. 89, 71-84 (2006).
3. Cowley, M.A. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661 (2003).
4. Cone, R.D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 27, 736-749 (2006).
5. Vaisse, C. et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106, 253-262 (2000).
6. Ford, E.S., Giles, W.H. & Dietz, W.H. Prevalence of the metabolic syndrome among US adults: fndings from the third National Health and Nutrition Examination Survey. J. Am. Med. Assoc. 287, 356-359 (2002).
7. Tschöp, M., Smiley, D.L. & Heiman, M.L. Ghrelin induces adiposity in rodents. Nature 407, 908-913 (2000).
8. Ma, X., Bruning, J. & Ashcroft, F.M. Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons. J. Neurosci. 27, 7125-7129 (2007).
9. Pocai, A., Obici, S., Schwartz, G.J. & Rossetti, L. A brain-liver circuit regulates glucose homeostasis. Cell Metab. 1, 53-61 (2005).
10. Sutton, G.M. et al. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or-4 receptors. Endocrinology 147, 2183-2196 (2006).
11. Chen, A.S. et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102 (2000).
12. Schoonjans, K. et al. Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep. 3, 1181-1187 (2002).
13. Lambert, G. et al. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J. Biol. Chem. 278, 2563-2570 (2003).
14. Cettour-Rose, P. & Rohner-Jeanrenaud, F. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143, 2277-2283 (2002).
15. Blüher, S. et al. Responsiveness to peripherally administered melanocortins in lean and obese mice. Diabetes 53, 82-90 (2004).
16. Enriori, P.J. et al. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 5, 181-194 (2007).
17. Rigotti, A. et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA 94, 12610-12615 (1997).
18. Varban, M.L. et al. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA 95, 4619-4624 (1998).
19. Tondu, A.L. et al. Insulin and angiotensin II induce the translocation of scavenger receptor class B, type I from intracellular sites to the plasma membrane of adipocytes. J. Biol. Chem. 280, 33536-33540 (2005).
20. Shetty, S., Eckhardt, E.R., Post, S.R. & van der Westhuyzen, D.R. Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes. Arterioscler. Thromb. Vasc. Biol. 26, 2125-2131 (2006).
21. Ginsberg, H.N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 106, 453-458 (2000).
22. Arai, T. et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler. Thromb. 14, 1129-1136 (1994).
23. Gruen, M.L. et al. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J. Lipid Res. 46, 2007-2014 (2005).
24. Lundåsen, T., Liao, W., Angelin, B. & Rudling, M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-defcient (ob/ob) mice. J. Biol. Chem. 278, 43224-43228 (2003).
25. Silver, D.L., Jiang, X.C. & Tall, A.R. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J. Biol. Chem. 274, 4140-4146 (1999).
26. Silver, D.L., Wang, N. & Tall, A.R. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J. Clin. Invest. 105, 151-159 (2000).
27. Rader, D.J. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116, 3090-3100 (2006).
28. Hasty, A.H. et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J. Biol. Chem. 276, 37402-37408 (2001).
29. Huby, T. et al. Knockdown expression and hepatic defciency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. J. Clin. Invest. 116, 2767-2776 (2006).
30. Zhang, Y. et al. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 115, 2870-2874 (2005).
31. Engelking, L.J. et al. Schoenheimer effect explained\feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. J. Clin. Invest. 115, 2489-2498 (2005).
32. Horton, J.D., Goldstein, J.L. & Brown, M.S. SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb. Symp. Quant. Biol. 67, 491-498 (2002).
33. Cummings, D.E. & Overduin, J. Gastrointestinal regulation of food intake. J. Clin. Invest. 117, 13-23 (2007).
34. Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S. & Schwartz, M.W. Central nervous system control of food intake and body weight. Nature 443, 289-295 (2006).
35. Coll, A.P., Farooqi, I.S. & Orahilly, S. The hormonal control of food intake. Cell 129, 251-262 (2007).
36. Lowell, B.B. & Spiegelman, B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 404, 652-660 (2000).
37. Ahrén, B. Autonomic regulation of islet hormone secretion\implications for health and disease. Diabetologia 43, 393-410 (2000).
38. Castañeda, T.R. et al. Obesity and the neuroendocrine control of energy homeostasis: the role of spontaneous locomotor activity. J. Nutr. 135, 1314-1319 (2005).
39. Lam, T.K. et al. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat. Med. 13, 171-180 (2007).
40. Nogueiras, R. et al. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117, 3475-3488 (2007).
41. Schnölzer, M., Alewood, P., Jones, A., Alewood, D. & Kent, S.B. In situ neutralization in Boc-chemistry solid-phase peptide synthesis. Rapid, high yield assembly of diffcult sequences. Int. J. Pept. Protein Res. 40, 180-193 (1992).
42. Pittman, R.C., Knecht, T.P., Rosenbaum, M.S. & Taylor, C.A. Jr. A nonendocytotic mechanism for the selective uptake of high-density lipoprotein-associated cholesterol esters. J. Biol. Chem. 262, 2443-2450 (1987).